Emergence of nanomedical devices for the diagnosis and treatment of cancer: the journey from basic science to commercialisation
by Marco Curreli, Arman H. Nadershahi, Gurinder Shahi
International Journal of Technology Transfer and Commercialisation (IJTTC), Vol. 7, No. 4, 2008

Abstract: Nanobiosensors and Near-Infrared Light Absorbing Nanomaterials (NIRLANs) may revolutionise the diagnosis and therapy of cancer. This paper briefly explains how nanomedical devices work and then analyses the issues involved in translating such concept devices into valuable commercial products. While oncology nanodevices have already demonstrated enormous potential in anti-cancer therapy, the benefits of these innovative medical products cannot be fully realised without safety and clinical efficacy testing, compliance with regulations, and adequate protection of intellectual property for commercialisation. While medical nanotechnology holds great promise for the diagnosis and treatment of cancers, the path to successful commercialisation poses numerous new challenges.

Online publication date: Fri, 31-Oct-2008

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Technology Transfer and Commercialisation (IJTTC):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com